Caricamento...
Antifibrinolytics for heavy menstrual bleeding
BACKGROUND: Heavy menstrual bleeding (HMB) is an important physical and social problem for women. Oral treatment for HMB includes antifibrinolytic drugs, which are designed to reduce bleeding by inhibiting clot‐dissolving enzymes in the endometrium. Historically, there has been some concern that usi...
Salvato in:
| Pubblicato in: | Cochrane Database Syst Rev |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Ltd
2018
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6494516/ https://ncbi.nlm.nih.gov/pubmed/29656433 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000249.pub2 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|